Slides
Page 1
Copyright © 2026 NAGASE & CO., LTD. FY2026 First Quarter Financial Briefing NAGASE&CO.,LTD. Stock exchange listing : Tokyo (Prime Market) Code number : 8012 August 4, 2026
Page 2
Copyright © 2026 NAGASE & CO., LTD. 2 Executive Summary FY2026 First Quarter Results The Company posted record-high net sales and profits at all levels. In Materials, earnings were strong due to soaring market prices caused by the situation in the Middle East. In Electronics, sales were strong for Nagase ChemteX formulated epoxy resins used in semiconductors for AI. In Life Sciences, the Prinova Group businesses in Solutions and Nutrition performed well. Gross profit margin improved by 1.0 percentage points while operating income ratio improved by 1.8 percentage points. FY2026 Earnings Projections Sales of formulated epoxy resins used in semiconductors for AI outperformed our expectations. The Prinova Group manufacturing business reported better-than-expected results from Solutions. ⚫ Due to the impact of the situation in the Middle East, we plan to reassess our full-year earnings forecast at the time of the second-quarter earnings, after closely assessing future market trends and demand. Impact of the Situation in the Middle East ⚫ The blockade of the Strait of Hormuz has led to a shortage of naphtha. The supply-demand situation is stable at present, thanks to supplies from the United States and other factors. ⚫ Naphtha prices peaked in April and after a downward trend, prices are currently on the rise again. ⚫ First-quarter performance was strong, driven by increased demand from customers preparing for unforeseen circumstances, the procurement of alternative products, and soaring commodity prices. ⚫ Leveraging our global network, which is one of our key strengths, we quickly sourced alternative products to maintain the chemicals supply chain. ⚫ We are managing inventory levels in preparation for future price declines.
Page 3
Copyright © 2026 NAGASE & CO., LTD. Contents ■ Consolidated Statements of Income ■ Operating Income by Segment : Two-Year Comparison ■ Segment Overview ■ Consolidated Balance Sheets ■ Consolidated Cash Flows ■ FY2026 Earnings Projection ■ Shareholder Returns <Appendix> Business Environment Surrounding NAGASE Segments Gross Profit by Region Gross Profit by Business & Segment : Two-Year Comparison Operating Income by Business & Segment : Two-Year Comparison Sales, Gross Profit, and Operating Income by Quarter Segment Overview Overview of Major Manufacturing Subsidiaries P４ P5 P6～P8 P9 P10 P11～P13 P14 * Beginning with fiscal 2026, we will provide separate disclosures for Prinova Group gross profit and operating income under the manufacturing and trading businesses. We have also restated results not disclosed in the previous period in accordance with the new classification. * We revised the allocation method for shared corporate expenses beginning this fiscal year to improve segment performance management. Accordingly, we have restated results for the previous period in accordance with the new allocations for comparison with the previous period. * Manufacturing figures represent the aggregate totals of manufacturing subsidiaries. * Trading business figures include the aggregate totals of NAGASE and our sales subsidiaries, as well as Corporate & Others and eliminations P17 P18 P19 P20 P21 P22～P24 P25～P27 3
Page 4
Copyright © 2026 NAGASE & CO., LTD. Consolidated Statements of Income * Impact from foreign exchange: Gross profit, +¥2.5 billion; Operating income, +¥0.9 billion ▶ Posted record-high net sales and profits at all levels for any first quarter. ▶ Gross profit increased with business growth and meeting customer demands reliably amid supply chain disruptions caused by the situation in the Middle East. ▶ Operating income increased. This increase was due in part to lower retirement benefit expenses related to the amortization of actuarial differences. 4 100 millions of yen FY2025 1Q FY2026 1Q Change Vs.PY Forecast Achievement Sales 2,373 2,797 424 118% 10,000 28% Gross profit 443 551 108 124% 1,980 28% <GP ratio> 18.7% 19.7% 1.0ppt － 19.8% － SG&A expenses 340 381 40 112% 1,530 25% Operating income 102 170 67 166% 450 38% ＜OP ratio＞ 4.3% 6.1% 1.8ppt － 4.5% － (excluding the effect of actuarial gains and losses) 103 159 56 155% 409 39% Ordinary income 106 180 73 169% 450 40% Profit Attributable to owners of the parent 75 146 71 195% 345 42% US$ Exchange rate (period average) @ 144.6 @ 159.5 @ 14.9 Weak yen @ 155.0 RMB Exchange rate (period average) @ 20.0 @ 23.4 @ 3.4 Weak yen @ 22.5
Page 5
Copyright © 2026 NAGASE & CO., LTD. ▶ Profit increased year on year across all segments. ▶ Corporate & Others increased by ¥0.9 billion. This increase was due to a decrease in retirement benefit expenses related to the amortization of actuarial differences. (Retirement benefit expense related to the amortization of actuarial differences: Approximately ¥0.3 billion in loss in fiscal 2025 and ¥4.0 billion in gain for fiscal 2026, equally prorated and recorded on a quarterly basis) Change in Operating Income By Segment (100 millions of yen) Operating Income by Segment (100 millions of yen) 5 * New allocation standards beginning this fiscal year. See the Contents page for details. Operating Income by Segment : Two-Year Comparison 31 １８ 7
Page 6
Copyright © 2026 NAGASE & CO., LTD. 6 Segment Overview: Materials Materials ▶ Gross profit rose ¥4.7 billion year on year. Operating income increased ¥3.1 billion year on year. <Manufacturing> ・ Sales of industrial hoses and civil engineering pipes increased in Nagase RooTAC Industries, Inc. <Trading> ・ Profit margins improved overall, supported by an upturn in market conditions due to developments in the Middle East. ・ In the chemicals business, the procurement of substitute products contributed to maintaining the supply chain. ・ Sales volume of resins for electrical and electronic equipment were level year on year. This result was driven by ongoing efforts to improve product mix. ・ Sales of resins, functional materials, and components for automotive applications were solid, due in part to new adoptions. * NAGASE and sales subsidiaries handle the sales function for certain manufacturing subsidiaries. Accordingly, the trading business records profit from the sale of products produced by manufacturing subsidiaries. * New allocation standards beginning this fiscal year. See the Contents page for details. 100 millions of yen FY2025 YTD FY2026 YTD Change Ratio Forecast Achievement Sales 1,189 1,403 214 18% 4,955 28% Gross profit 181 228 47 26% 776 29% <profit ratio> 15.2% 16.3% 1.1ppt － 15.7% － Operating income 50 81 31 63% 196 42% <profit ratio> 4.2% 5.8% 1.6ppt － 4.0% － Manufacturing 5 9 3 71% Trading 44 72 28 63%
Page 7
Copyright © 2026 NAGASE & CO., LTD. 7 Segment Overview: Electronics Electronics ▶ Gross profit rose ¥2.4 billion year on year. Operating income increased ¥1.8 billion year on year. <Manufacturing> ・ Nagase ChemteX saw an increase in sales of formulated epoxy resins. Despite weak performance in sales for mobile device applications, the business delivered strong sales of product for AI semiconductors. ・ The Pac Tech Group continued to perform well. This result was due to the strong performance in bumping contract services. <Trading> ・ Sales of semiconductor materials increased in Greater China. 100 millions of yen FY2025 YTD FY2026 YTD Change Ratio Forecast Achievement Sales 415 491 76 18% 1,750 28% Gross profit 103 127 24 23% 479 27% <profit ratio> 24.8% 25.9% 1.0ppt － 27.4% － Operating income 30 49 18 60% 144 34% <profit ratio> 7.4% 10.0% 2.6ppt － 8.2% － Manufacturing 9 17 7 79% Trading 21 32 10 52% * NAGASE and sales subsidiaries handle the sales function for certain manufacturing subsidiaries. Accordingly, the trading business records profit from the sale of products produced by manufacturing subsidiaries. * New allocation standards beginning this fiscal year. See the Contents page for details.
Page 8
Copyright © 2026 NAGASE & CO., LTD. 8 Segment Overview: Life Sciences Life Sciences ▶ Gross profit increased ¥3.7 billion year on year. Operating income increased ¥0.7 billion year on year. <Manufacturing> ・ The Prinova Group manufacturing business posted a strong sales increase in Solutions and Nutrition. ・ Nagase Viita offset rising raw materials prices through an increase in cosmetics materials sales and other factors, maintaining sales level year on year. <Trading> ・ While sales increased in the Prinova Group's trading business, profit declined due to higher logistics costs and other selling, general, and administrative expenses. ・ Sales of intermediates and pharmaceutical raw materials remained level year on year. 100 millions of yen FY2025 YTD FY2026 YTD Change Ratio Forecast Achievement Sales 768 902 133 17% 3,294 27% Gross profit 157 195 37 24% 724 27% <profit ratio> 20.5% 21.6% 1.1ppt － 22.0% － Operating income 21 29 7 37% 72 40% <profit ratio> 2.8% 3.2% 0.5ppt － 2.2% － Manufacturing 6 20 13 206% Trading 14 8 (5) (40%) * NAGASE and sales subsidiaries handle the sales function for certain manufacturing subsidiaries. Accordingly, the trading business records profit from the sale of products produced by manufacturing subsidiaries. * New allocation standards beginning this fiscal year. See the Contents page for details. * Beginning with FY2026, we will provide separate disclosures Prinova Group gross profit and operating income under the manufacturing and trading businesses. See the Contents page for details.
Page 9
Copyright © 2026 NAGASE & CO., LTD. Consolidated Balance Sheets ▶ Current assets increased. Cash and deposits decreased while trade accounts receivable and inventories rose with business growth. ▶ Non-current assets increased. The increase was due to an increase in the market value of investment securities, among other factors. ▶ Liabilities increased. The increase was due to an increase in trade accounts payable and commercial paper, among other factors. ▶ Net assets increased. The increase was due to the posting of profit attributable to owners of the parent, as well as an increase in the valuation of other securities, a foreign currency translation adjustment, and other factors. 9 100 millions of yen 2026/03 2026/06 Change Details Total Current Assets 5,663 6,161 498 (Cash&deposits) 455 410 (45) (Trade account receivable) 3,214 3,541 326 (Inventories) 1,775 1,953 177 Total non-current assets 3,052 3,259 207 (Investments in security) 875 996 120 Total assets 8,715 9,421 705 Current Liab. 2,970 3,415 445 C.P.＋210 (Trade account payable) 1,598 1,753 155 Non-current Liab. 1,404 1,444 39 Total Liab. 4,375 4,860 485 Shareholders' equity 3,138 3,228 90 Accum. Other Comprehensive Income 1,115 1,239 124 Other Securities Valuation Adjustment＋78、 Translation Adjustments＋54 Non-controlling interest 85 91 6 Total net assets 4,340 4,560 220 Working capital 3,391 3,740 349 Shareholders' equity ratio 48.8% 47.4% (1.4ppt) Interest-bearing debt 1,910 2,163 253 NET D/E ratio 0.34 0.39 0.05
Page 10
Copyright © 2026 NAGASE & CO., LTD. Consolidated Cash Flows ▶ Net cash used in operating CF amounted to ¥21.2 billion. This result was mainly due to a decrease in cash of ¥30.6 billion due to an increase in working capital. ▶ Net cash used in Investing CF amounted to ¥4.1 billion. This result was mainly due to an expenditure of ¥3.4 billion to purchase property, plant and equipment. ▶ As a result, free cash flow amounted to a net decrease of ¥25.3 billion. ▶ Cash from financing CF amounted to ¥18.1 billion. This result was mainly due to a ¥21 billion increase in commercial paper. ▶ As a result, cash and cash equivalents decreased ¥5.3 billion. 10 100 millions of yen FY2025 1Q YTD FY2026 1Q YTD Operating CF 7 (212) (Income before income taxes) 105 181 (Depreciation and amortization) 43 53 (Change in working capital) (36) (306) (Other) (104) (141) Investing CF (189) (41) (Fixed asset investment) (194) (46) (Other) 5 5 Free CF (182) (253) Financing CF 61 181 (Share buybacks) (46) 0 (Dividends paid) (48) (56) (Change in loans and bonds) 163 244 (Other) (6) (6) Effects of exchange rate (43) 19 Net increase / decrease in cash and cash equivalents (164) (53)
Page 11
Copyright © 2026 NAGASE & CO., LTD. FY2026 Earnings Projection (No Change) * Approximate impact on operating income of a ¥1 depreciation: USD +¥50 million; RMB +¥400 million (Exchange rate sensitivity is estimated based on the assumptions as of the earnings forecast announced in May 2026.) 100 milions of yen FY2025 Actual FY2026 Forecast Change Vs.PY Sales 9,727 10,000 272 103% Gross profit 1,876 1,980 103 105% <GP ratio> 19.3% 19.8% 0.5ppt － SG&A expenses 1,429 1,530 100 107% Operating income 447 450 2 101% <OP ratio> 4.6% 4.5% (0.1ppt) － (excluding the effect of actuarial gains and losses) 450 409 (41) 91% Ordinary income 440 450 9 102% Profit attributable to owners of the parent 331 345 13 104% US$ Exchange rate (period average) @ 150.7 @ 155.0 @ 4.3 Weak yen RMB Exchange rate (period average) @ 21.2 @ 22.5 @ 1.3 Weak yen 11
Page 12
Copyright © 2026 NAGASE & CO., LTD. FY2026 Earnings Projection By Segment (No Change) * We revised the allocation method for shared corporate expenses beginning this fiscal year to improve segment performance management. * Results for the previous and current fiscal years and forecasts for the current fiscal year presented in the table above represent the new classifications . 100 millions of yen FY2025 Actual FY2026 Forecast Change Vs.PY Materials Sales 4,905 4,955 49 101% Gross profit 757 776 18 102% <profit ratio> 15.4% 15.7% 0.2ppt — Operating income 214 196 (18) 91% <profit ratio> 4.4% 4.0% (0.4ppt) — Electronics Sales 1,728 1,750 21 101% Gross profit 453 479 25 106% <profit ratio> 26.2% 27.4% 1.2ppt — Operating income 153 144 (9) 94% <profit ratio> 8.9% 8.2% (0.6ppt) — Life Sciences Sales 3,092 3,294 202 107% Gross profit 664 724 60 109% <profit ratio> 21.5% 22.0% 0.5ppt — Operating income 86 72 (14) 84% <profit ratio> 2.8% 2.2% (0.6ppt) — Corporate & Others Sales 0 0 0 53% Gross profit 1 0 (1) 5% Operating income (7) 38 45 ー Total Sales 9,727 10,000 272 103% Gross profit 1,876 1,980 103 105% <profit ratio> 19.3% 19.8% 0.5ppt — Operating income 447 450 2 101% <profit ratio> 4.6% 4.5% (0.1ppt) — 12
Page 13
Copyright © 2026 NAGASE & CO., LTD. FY2026 Earnings Projections by Major Manufacturing Subsidiaries (No Change) 100 milions of yen FY2025 Actual FY2026 Forecast Change Vs.PY Nagase ChemteX Group Sales 330 356 25 108% Gross profit 117 125 8 107% <profit ratio> 35.5% 35.3% (0.2ppt) ー Operating income 37 37 (0) 100% <profit ratio> 11.5% 10.6% (0.9ppt) ー Nagase Viita Co., Ltd. Sales 346 350 3 101% Gross profit 139 136 (3) 98% <profit ratio> 40.3% 38.9% (1.4ppt) ー Operating income 57 51 (6) 89% <profit ratio> 16.5% 14.6% (2.0ppt) ー Goodwill amortization etc. 18 18 - 100% Operating income after amortization burden 38 32 (6) 84% Prinova Group Sales 2,142 2,420 277 113% Gross profit 348 406 57 116% <profit ratio> 16.3% 16.8% 0.5ppt ー Operating income 69 80 10 115% <profit ratio> 3.3% 3.3% 0.0ppt ー Goodwill amortization etc. 27 28 0 104% Operating income after amortization burden 42 51 9 122% 13 * Beginning in FY 2026, the figures for the Nagase ChemteX Group include results from Nagase ChemteX (Wuxi) Corp. and Nagase ChemteX America LLC. Accordingly, we have restated results for the previous period in accordance with this new policy for comparative purposes.
Page 14
Copyright © 2026 NAGASE & CO., LTD. 5,023 5,230 5,456 5,691 6,514 8,245 9,147 9,888 10,358 11,020 1,776 1,956 952 6,006 5,662 8,001 17,000 22,999 3,000 6,799 7,186 5,456 6,643 12,520 13,907 17,148 26,888 33,357 39.5 35.6 36.0 35.2 48.3 58.9 76.5 105.4 100.7 0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 90.0 100.0 110.0 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026 Forecast Total Dividend Share Buyback Total Payout Ratio Shareholder Returns ▶ We plan to pay ¥27 per share for the full year, consisting of an interim dividend of ¥13 per share and a year-end dividend of ¥14 per share (projecting a 17th consecutive year of dividend increases). ▶ We approved a resolution in August 2026 to conduct ¥3.0 billion in share buybacks (planned schedule: August 5 through September 30, 2026). ▶ Shareholder Return Policy: We will execute stable dividend increases over the three years through fiscal 2028, with flexible share buybacks (guideline: 30% EPS growth over three years). * FY2026 year-end dividend to be submitted for approval to the 112th general meeting of shareholders scheduled for June 2027. * Per-share dividends are presented on a post-split basis, reflecting the four-for-one stock split that went into effect April 1, 2026. ¥10.00 Millions of yen (％) Dividend per Share (¥) ¥10.50 ¥11.00 ¥11.50 ¥13.50 ¥17.50 ¥20.00 ¥22.50 ¥25.00 ¥27.00 14 Flexible share buybacks
Page 15
15 We recognize our responsibility to society and offer beneficial products and services while maintaining the highest standards of integrity. Through our growth, we will contribute to society and enrich the lives of our employees. Management Philosophy
Page 16
Copyright © 2026 NAGASE & CO., LTD. These presentation materials contain projections based on forward-looking assumptions, forecasts, and plans as of August 4, 2026 Actual earnings may differ from projections due to risks and uncertainties in the future global economy, competitive landscape, currency exchange rates, etc. https://www.nagase.co.jp/english/ir/ ■NAGASE Group Investor Relations Website: https://www.nagase.co.jp/english/contact/ir/ ■Inquiries:
Page 17
Copyright © 2026 NAGASE & CO., LTD. Business Environment Surrounding NAGASE Segments 17 Appendix Review Industry Segment Electrical and Electronic Equipment Demand and resin market conditions saw slight growth YoY. Demand and resin market conditions to remain flat.Business opportunities to increase due to OA industrial reorganization. Automobiles EV demand declined, and regional polarization in automotive production intensified, resulting in a slight overall decrease YoY. Automobile production volumes remained flat. Coatings Automotive applications decreased slightly. Construction applications decreased, resulting in a slight decline in overall performance. Automotive and construction applications unlikely to recover, with overall performance likely to see a slight decline. Semiconductors AI drove growth, but rising memory prices kept smartphone and PC demand flat.Demand for domestic production expanded in China.Overall YoY performance was favorable. AI is likely to drive growth, but a decline in the number of smartphones, etc., stemming from memory shortages, to delay a full recovery.Performance in China to remain strong, but U.S.–China tensions remain a concern. Smartphones High-end sales remained strong, and mid-range and low-end sales segments saw slight growth due to the growing adoption of low-priced models; however, the overall market was flat YoY due to a slowdown in China. High-end sales to benefit from greater AI usage, but memory shortages are likely to be a headwind.Mid-range and low-end sales to face difficulties, with overall performance likely to decline. Food Food ingredient sales performed well in Japan.Market growth in food ingredients and nutrition led to favorable performance in Europe and the U.S. Food ingredient sales performed well in Japan.Market growth in food ingredients and nutrition likely to continue to result in favorable performance in Europe and the U.S. Cosmetics Industry structure changed due to weak consumer demand in China, a key end market, and intensified competition from emerging brands. Changes in industry structure to continue, while high-value-added strategies by global players and a shift to Southeast Asia by Japanese companies support a gradual demand recovery. Medical Demand for additives, APIs, and intermediates remained strong throughout the year, driven by outsourcing of brand-name products and generic expansion following regulatory changes. Outsourcing trends for brand-name products and further expansion of the generics market likely to continue, supporting steady demand for additives and APIs. ・May not always be consistent with industry trends ・Segment name changes beginning f iscal 2026: Functional Materials, Advanced Materials, and Mobility are now “Materials;” Electronics & Energy is now “Electronics;” and Life & Healthcare is now “Life Sciences” ・Fiscal 2026 trends represent the industry trends underlying our full-year earnings forecast, announced on May 7, 2026. As we have not revised our forecasts, the trends presented here are unchanged as well FY2025 Trends FY2026 Trends Materials Electronics Life Sciences
Page 18
Copyright © 2026 NAGASE & CO., LTD. Domestic 209 Domestic 255 Overseas 233 Overseas 295 Total 443 Total 551 Overseas gross profit ratio 52.7% Overseas gross profit ratio 53.6% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0% 70.0% 80.0% 90.0% 100.0% 0 50 100 150 200 250 300 350 400 450 500 550 600 FY2025 1Q FY2026 1Q Gross Profit by Region Domestic & Overseas Gross Profit(100 millions of yen) Overseas Gross Profit by Region(100 millions of yen) * Domestic figures under Domestic & Overseas Gross Profit include inter-regional adjustments 18 Greater China 67 Greater China 90 ASEAN 45 ASEAN 57 Americas 82 Americas 94 Europe 33 Europe 48 Other 3 Other 4 Total 233 Total 295 0 100 200 300 FY2025 1Q FY2026 1Q 1.7% 14.4% 16.2% 1.5% 35.5% 32.1% 19.6% 19.5% 28.8% 30.6% Appendix
Page 19
Copyright © 2026 NAGASE & CO., LTD. 19 Gross Profit Quarterly Trend (100 millions of yen) Change in Gross Profit By Segment (100 millions of yen)Gross Profit By Business & Segment (100 millions of yen) * Beginning with FY2026, we will provide separate disclosures Prinova Group gross profit and operating income under the manufacturing and trading businesses. See the Contents page for details. Appendix Gross Profit by Business & Segment : Two-Year Comparison
Page 20
Copyright © 2026 NAGASE & CO., LTD. Operating Income By Business & Segment (100 millions of yen) * Calculations of composition ratios by business type do not include Corporate & Others. * New allocation standards beginning this fiscal year. See the Contents page for details. * Beginning with FY2026, we will provide separate disclosures Prinova Group gross profit and operating income under the manufacturing and trading businesses. See the Contents page for details. 20 Change in Operating Income By Segment (100 millions of yen) Appendix Operating Income by Business & Segment : Two-Year Comparison ３１ １８ ７ Operating Income Quarterly Trend (100 millions of yen)
Page 21
Copyright © 2026 NAGASE & CO., LTD. Sales, Gross Profit, and Operating Income by Quarter 21 Appendix 100 millions of yen Quarterly results FY2026 Forecast Achieve ment １Q ２Q ３Q ４Q YTD FY2025 Actual Sales FY2026 2,797 2,797 10,000 28% FY2025 2,373 2,424 2,443 2,487 2,373 9,727 Change 424 424 272 Gross profit FY2026 551 551 1,980 28% FY2025 443 465 479 487 443 1,876 Change 108 108 103 <profit ratio> FY2026 19.7% 19.7% 19.8% FY2025 18.7% 19.2% 19.6% 19.6% 18.7% 19.3% Manufacturing FY2026 162 162 FY2025 119 135 147 150 119 552 Trading FY2026 388 388 FY2025 323 330 332 337 323 1,324 Operating income FY2026 170 170 450 38% FY2025 102 108 121 115 102 447 Change 67 67 2 <profit ratio> FY2026 6.1% 6.1% 4.5% FY2025 4.3% 4.5% 5.0% 4.6% 4.3% 4.6% Manufacturing FY2026 46 46 FY2025 21 21 35 34 21 113 Trading FY2026 123 123 FY2025 80 86 85 80 80 333 * Beginning with FY2026, we will provide separate disclosures Prinova Group gross profit and operating income under the manufacturing and trading businesses. See the Contents page for details.
Page 22
Copyright © 2026 NAGASE & CO., LTD. Segment Overview: Materials 22 Materials Appendix 100 millions of yen Quarterly results FY2026 Forecast Achieve ment １Q ２Q ３Q ４Q YTD FY2025 Actual Sales FY2026 1,403 1,403 4,955 28% FY2025 1,189 1,240 1,239 1,236 1,189 4,905 Change 214 214 49 Gross profit FY2026 228 228 776 29% FY2025 181 190 191 194 181 757 Change 47 47 18 <profit ratio> FY2026 16.3% 16.3% 15.7% FY2025 15.2% 15.3% 15.4% 15.8% 15.2% 15.4% Manufacturing FY2026 25 25 FY2025 20 21 22 21 20 85 Trading FY2026 202 202 FY2025 161 168 168 173 161 671 Operating income FY2026 81 81 196 42% FY2025 50 51 53 59 50 214 Change 31 31 (18) <profit ratio> FY2026 5.8% 5.8% 4.0% FY2025 4.2% 4.2% 4.3% 4.8% 4.2% 4.4% Manufacturing FY2026 9 9 FY2025 5 5 6 6 5 24 Trading FY2026 72 72 FY2025 44 45 46 52 44 190 * New allocation standards beginning this fiscal year. See the Contents page for details.
Page 23
Copyright © 2026 NAGASE & CO., LTD. Segment Overview: Electronics 23 Electronics Appendix 100 millions of yen Quarterly results FY2026 Forecast Achieve ment １Q ２Q ３Q ４Q YTD FY2025 Actual Sales FY2026 491 491 1,750 28% FY2025 415 431 442 439 415 1,728 Change 76 76 21 Gross profit FY2026 127 127 479 27% FY2025 103 115 120 114 103 453 Change 24 24 25 <profit ratio> FY2026 25.9% 25.9% 27.4% FY2025 24.8% 26.7% 27.3% 26.0% 24.8% 26.2% Manufacturing FY2026 49 49 FY2025 35 47 51 49 35 184 Trading FY2026 77 77 FY2025 67 67 69 65 67 268 Operating income FY2026 49 49 144 34% FY2025 30 39 46 36 30 153 Change 18 18 (9) <profit ratio> FY2026 10.0% 10.0% 8.2% FY2025 7.4% 9.2% 10.6% 8.3% 7.4% 8.9% Manufacturing FY2026 17 17 FY2025 9 15 19 13 9 57 Trading FY2026 32 32 FY2025 21 24 27 23 21 96 * New allocation standards beginning this fiscal year. See the Contents page for details.
Page 24
Copyright © 2026 NAGASE & CO., LTD. Segment Overview: Life Sciences 24 Life Sciences Appendix 100 millions of yen Quarterly results FY2026 Forecast Achieve ment １Q ２Q ３Q ４Q YTD FY2025 Actual Sales FY2026 902 902 3,294 27% FY2025 768 751 760 810 768 3,092 Change 133 133 202 Gross profit FY2026 195 195 724 27% FY2025 157 160 167 179 157 664 Change 37 37 60 <profit ratio> FY2026 21.6% 21.6% 22.0% FY2025 20.5% 21.3% 22.0% 22.1% 20.5% 21.5% Manufacturing FY2026 87 87 FY2025 63 66 72 79 63 282 Trading FY2026 107 107 FY2025 93 93 94 99 93 381 Operating income FY2026 29 29 72 40% FY2025 21 17 21 25 21 86 Change 7 7 (14) <profit ratio> FY2026 3.2% 3.2% 2.2% FY2025 2.8% 2.4% 2.8% 3.2% 2.8% 2.8% Manufacturing FY2026 20 20 FY2025 6 1 9 15 6 32 Trading FY2026 8 8 FY2025 14 16 11 10 14 53 * New allocation standards beginning this fiscal year. See the Contents page for details. * Beginning with FY2026, we will provide separate disclosures Prinova Group gross profit and operating income under the manufacturing and trading businesses. See the Contents page for details.
Page 25
Copyright © 2026 NAGASE & CO., LTD. 25 ▶ Gross profit increased by ¥1.0 billion year on year. Operating income increased by ¥0.8 billion year on year. ・ Operating income stemming from sales of formulated epoxy resins increased. LMC sales of products for AI semiconductors increased, while sales of products for mobile devices declined. a-SMC has been adopted as an encapsulant for high- performance IC package substrates used in advanced semiconductors, and we have begun small-volume production. ・ Operating income increased with sales of photolithography materials. Sales remained level year on year; however, cost reductions stemming from efficiency initiatives contributed positively to the results. Appendix LMC： Liquid Molding Compound a-SMC： Advanced Sheet Molding Compound Overview of Major Manufacturing Subsidiaries: Nagase ChemteX Group 100 millions of yen Quarterly results FY2026 Forecast Achiev ement １Q ２Q ３Q ４Q YTD FY2025 Actual Sales FY2026 102 102 356 29% FY2025 79 81 85 83 79 330 Change 23 23 25 Gross profit FY2026 38 38 125 31% FY2025 28 29 29 29 28 117 Change 10 10 8 <profit ratio> FY2026 37.8% 37.8% 35.3% FY2025 35.9% 36.4% 34.2% 35.5% 35.9% 35.5% Operating income FY2026 17 17 37 47% FY2025 9 9 9 8 9 37 Change 8 8 (0) <profit ratio> FY2026 17.1% 17.1% 10.6% FY2025 12.0% 12.1% 11.5% 10.2% 12.0% 11.5% * The sales functions of Nagase ChemteX are handled by our company and its sales subsidiaries, and profits from Nagase ChemteX's business are also recognized under the trading business * Beginning in FY 2026, the figures for the Nagase ChemteX Group include results from Nagase ChemteX (Wuxi) Corp. and Nagase ChemteX America LLC. Accordingly, we have restated results for the previous period in accordance with this new policy for comparative purposes.
Page 26
Copyright © 2026 NAGASE & CO., LTD. Overview of Major Manufacturing Subsidiaries: Nagase Viita ▶ Gross profit increased by ¥0.2 billion year on year. Operating income increased by ¥0.1 billion year on year. ・ Operating income declined for food ingredients sales. While sales volume was level year on year, rising raw materials prices had a negative impact on results. ・ Operating income increased with sales of cosmetic materials. The increase was due to higher sales volume both in Japan and overseas. 26 Appendix * The sales functions of Nagase Viita are handled by our company and its sales subsidiaries, and profits from Nagase Viita's business are also recognized under the trading business 100 millions of yen Quarterly results FY2026 Forecast Achiev ement １Q ２Q ３Q ４Q YTD FY2025 Actual Sales FY2026 93 93 350 27% FY2025 86 85 90 84 86 346 Change 6 6 3 Gross profit FY2026 37 37 136 28% FY2025 35 34 36 32 35 139 Change 2 2 (3) <profit ratio> FY2026 40.5% 40.5% 38.9% FY2025 41.2% 41.0% 40.6% 38.1% 41.2% 40.3% Operating income FY2026 16 16 51 33% FY2025 15 13 15 12 15 57 Change 1 1 (6) <profit ratio> FY2026 18.1% 18.1% 14.6% FY2025 17.8% 16.3% 17.2% 14.8% 17.8% 16.5% Goodwill amortization etc. FY2026 4 4 18 FY2025 4 4 4 4 4 18 Change 0 0 0 Operating income after amortization burden FY2026 12 12 32 38% FY2025 10 9 10 7 10 38 Change 1 1 (6)
Page 27
Copyright © 2026 NAGASE & CO., LTD. ▶ Gross profit increased by ¥2.3 billion year on year. Operating income increased by ¥0.5 billion year on year. ・ The manufacturing business saw an increase in operating income. This increase was due to a narrower loss in the Nutrition business stemming from increased sales, as well as higher sales in the Solutions business. ・ The trading business posted a decline in operating income. Although sales and gross profit from food ingredients sales increased, logistics costs and other selling, general, and administrative expenses were higher. Overview of Major Manufacturing Subsidiaries: Prinova Group 27 Appendix * Beginning with FY2026, we will provide separate disclosures Prinova Group gross profit and operating income under the manufacturing and trading businesses. See the Contents page for details. 100 millions of yen Quarterly results FY2026 Forecast Achievem ent １Q ２Q ３Q ４Q YTD FY2025 Actual Sales FY2026 641 641 2,420 26% FY2025 539 530 514 557 539 2,142 Change 101 101 277 Gross profit FY2026 105 105 406 26% FY2025 82 86 84 95 82 348 Change 23 23 57 <profit ratio> FY2026 16.4% 16.4% 16.8% FY2025 15.2% 16.2% 16.5% 17.2% 15.2% 16.3% Manufacturing FY2026 36 36 FY2025 23 24 26 35 23 109 Trading FY2026 68 68 FY2025 58 61 58 60 58 239 Operating income FY2026 22 22 80 28% FY2025 16 19 15 18 16 69 Change 5 5 10 <profit ratio> FY2026 3.6% 3.6% 3.3% FY2025 3.1% 3.6% 3.0% 3.3% 3.1% 3.3% Manufacturing FY2026 9 9 FY2025 0 (1) 3 10 0 13 Trading FY2026 13 13 FY2025 15 20 12 7 15 56 Goodwill amortization etc. FY2026 6 6 26 FY2025 6 6 6 7 6 27 Change (0) (0) (0) Operating income after amortization burden FY2026 16 16 53 30% FY2025 9 12 8 11 9 42 Change 6 6 11 Manufacturing FY2026 5 5 FY2025 (3) (5) (0) 6 (3) (2) Trading FY2026 10 10 FY2025 13 17 9 4 13 45